The flagellin component FliC of Salmonella typhimurium is capable of activating the innate immune system via specific interactions with TLR5 and can also act as a carrier of foreign antigen to elicit antigen-specific immune responses. Thus, we constructed an attenuated Salmonella strain SL5928(fliC/esat) expressing chimeric flagellin that contained the ESAT-6 antigen coding sequence of Mycobacterium tuberculosis inserted into the highly variable region of the Salmonella flagellin coding gene fliC i . The chimeric flagellin functioned normally, as demonstrated using a flagella swarming assay and electron microscopy. To analyze the effects of chimeric flagellin, the cell-mediated immune response and cytotoxic T lymphocyte (CTL) effects specific for ESAT-6 antigen were tested after intranasal immunization of mice with flagellated Salmonella SL5928(fliC/esat). The results showed that SL5928(fliC/esat) intranasal immunization can strongly elicit an ESAT-6-specific T helper (Th) 1-type immune response in mucosal lymphoid tissues, such as nasopharynx-associated lymph nodes, lung and Peyer's patches, and a Th1/Th2 response was elicited in spleen and mesenteric lymph nodes. Furthermore, intranasal immunization of SL5928(fliC/esat) produced efficient CTL effects, as demonstrated using a 5-and 6-carboxyfluorescein diacetate succinimidyl ester (CFSE) assay. Thus, our study revealed that Salmonella flagellin acts as a carrier for foreign antigen and triggers strong Th1 and CTL responses during intranasal immunization. Chimeric flagellin is potentially an effective strategy for the development of novel vaccines against tuberculosis in humans and animals.
INTRODUCTION
Tuberculosis (TB) remains a major health problem for both humans and animals worldwide. Although the Bacille Calmette-Guérin (BCG) vaccine is widely administered to prevent this disease, its efficacy remains unpredictable.
1,2 Therefore, there is an urgent need to develop more effective vaccines and vaccination strategies against TB. Cellmediated immunity is thought to be essential for protection against TB, 3 with critical involvement of CD4 1 Th1 lymphocytes. 4 Furthermore, there is evidence that CD8 1 T cells, 5, 6 as well as unconventional T cells, contribute to optimal protection. 4, 7 Mycobacterium tuberculosis (MTB) infection often occurs through the upper respiratory tract. Intranasal (i.n.) immunization with either live BCG or killed-BCG formulated in an adjuvant or recombinant adenovirus-based vaccines has been shown to provide protection against MTB. 8 In addition, i.n. immunization of mice with an adenoviral-based vaccine expressing Ag85A 9 or microparticles encapsulated with ESAT-6 elicited antigen-specific CD4 1 and CD8 1 T cells capable of interferon (IFN)-c production and cytotoxic activity in the airways, lungs and mediastinal lymph nodes. 10 Furthermore, a previous study indicated that recombinant flagellin containing foreign antigens elicited protective immune responses in the absence of additional adjuvant. 11 Effects of flagellin on CD4 1 T-cell proliferative and cytokine responses have also been reported. 12 Salmonella flagellins are flexible adjuvants and induce adaptive immune responses when administered by different routes or in vaccine formulations. 13 Therefore, the aim of the present study was to assess whether efficient cellmediated immune responses and specific CTL effects could be stimulated by i.n. administration of flagellated Salmonella containing the ESAT-6 antigen coding sequences of MTB inserted in the highly variable region of Salmonella flagellin gene fliC i .
MATERIALS AND METHODS

Bacterial strains and plasmid
Escherichia coli strains DH5a and BL21 (DE3) and Salmonella typhimurium (Stm) (LT2) were from our laboratory stocks. Salmonella dublin SL1438 (1,9,12:2:2) and SL5928 (1,9,12:2:2; Amp 2 , Tet 1 , fliC i ::Tn10) were kindly provided by Dr Bruce AD Stocker (Stanford University, School of Medicine, Stanford, CA, USA). Phage P22 Ht int and Stm LB5000 (1,4,12:2:2; r 2 m 2 flaA66, Amp 2 ) were kindly provided by Dr AD Harshey (University of Texas, Austin, TX, USA). pYUB412 plasmid was provided by Dr. Claude Leclerc (Pasteur Institute, Paris).
Mice
Six-to eight-week-old female C57BL/6 mice were purchased from the Comparative Medical Center of Yangzhou University (Yangzhou, China) and housed at the Animal Biosafety facilities. Animal experiments were conducted in strict accordance with guidelines provided by the Animal Care and Ethics Committee of Yangzhou University.
Construction and cloning of chimeric flagellin gene fliC/esat For cloning of the ESAT-6 encoding sequence, the esxA gene was amplified from the pYUB412 plasmid using esat-1 (59-AAT AGT ACT ATG ACA GAG CAG CAG TGG-39) and esat-2 (59-C GTA ATA TTT TGC GA A CAT CCC AGT GAC-39) primers. PCR products were purified and used in the following experiments. The fliC i gene encoding the phase I flagellin was amplified by PCR from Stm (LT2) genomic DNA using fliC-1 (59-ATA GAA TTC AAG GAA AAG ATC ATG GCA CAA-39) and fliC-2 (59-TCA AAG CTT AAC GCA GTA AAG AGA G-3') primers. The fliC i gene product was purified and amplified using an overlap PCR and further used to clone the chimeric flagellin gene fliC/esat. The coding sequence corresponding to the Nterminal domain of flagellin was amplified using fliC-1 and F-E-2 (59-CCA CTG CTG CTC TGT CAT AGT ACT ATT GTC TAA A-39) primers, and the C-terminal domain of flagellin was amplified using F-E-1 (59-GTC ACT GGG ATG TTC GCA AAA TAT TAC GCC AAA-39) and fliC-2 primers. The two PCR products were fliC-N and fliC-C, respectively. The fliC/esat-1 fragments were cloned by overlap PCR using fliC-1 and esat-2 primers to amplify the fliC-N and ESAT-6 purified PCR products. The fliC/esat-2 fragments were cloned by overlap PCR using esat-1 and fliC-2 primers to amplify the fliC-C and ESAT-6 purified PCR products. A chimeric fragment of fliC/esat was amplified from fliC/esat-1 and fliC/esat-2 purified PCR products by overlap PCR using fliC-1 and fliC-2 primers. The chimeric fragment carried the incomplete fliC coding sequence, in which the coding region for amino-acid residues 205-232 of flagellin had been replaced with the entire ESAT-6 coding sequence (Figure 1 ). The chimeric fliC/ esat gene PCR products were purified, digested with EcoRI and HindIII and ligated into a pET30(a) expression vector to form the pET-fliC/ esat plasmid.
P22 phage transduction
The pET-fliC/esat plasmid was electrotransformed into Stm LB5000. The recombinant bacteria, LB5000 (pET-fliC/esat) (donor strain), were grown in LB broth overnight. Ten milliliters of P22 broth were added to 200 ml of the LB culture and incubated at 37 uC on a shaker for 10 h. The donor strain/phage mixture was centrifuged for 5 min (8000 g) to pellet the cell debris, and the supernatant was collected. Several drops of CHCl 3 were added to the supernatant before being vortexed and stored at 4 uC. The recipient strain Salmonella dublin SL5928 was grown overnight in 1-ml LB. Twenty microliters of the phage lysate was added to 200 ml of the overnight SL5928 culture and incubated at 37 uC on a shaker for 1 h. Finally, the mixture was spread onto LB agar containing 50 mg/ml of kanamycin.
Swarming assays
Non-motile S. dublin SL5928, flagellated SL5928(fliC/esat) and SL5928(fliC) colonies were punctured using a needle and placed into 0.4% semisolid medium tubes (100 ml: tryptone 10 g, NaCl 5 g, agar 0.4 g) that were incubated at 37 uC for 6-8 h.
Electron microscopy Negative staining of bacteria for electron microscopy was performed with 2% phosphotungstic acid as described by Hayat and Miller. 14 
Western blot assay
Flagellin of SL5928(fliC) and chimeric flagellin of SL5928(fliC/esat) were extracted by acid treatment followed by ammonium sulfate precipitation. 15 Under these experimental conditions, the extracted fraction was represented mainly by polymeric flagellin. The purified flagellin extracts were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and western blot analysis 16 using a murine anti-ESAT-6 monoclonal antibody (mAb) HYB 076-08 (Abcam, Cambridge, Massachusetts, USA).
Immunization of mice
Flagellated Salmonella SL5928(fliC/esat) or non-flagellated Salmonella SL5928 were harvested at an optical density of 0.8. Each bacterial pellet was then resuspended in phosphate-buffered saline (PBS) with a concentration of 5310 8 colony-forming units/ml. The immunization of C57BL/6 mice (6-8 weeks old) was performed as described previously. 17 Briefly, the mice were anesthetized by intraperitoneal injection with 0.1 ml of 1% pentobarbital sodium and immunized i.n. with 1310 7 colony-forming units SL5928(fliC/esat) and SL5928 on days 0 and 18, respectively. The negative control group was immunized i.n. with PBS.
Cell isolation
Cells were prepared from the spleens, lungs, Peyer's patches (PPs), mesenteric lymph nodes (MLNs) and nasopharynx-associated lymph nodes (NALTs) of immunized mice. Single cells were obtained from each of these tissues by pressing the organs through a stainless steel mesh and centrifuging at 200 g for 10 min at 4 uC. Lung and spleen cell suspensions were prepared through a murine Ez-sep (Dakewe Biotech Company, Shenzhen, China) density-gradient centrifugation (800 g for 25 min at 4 uC). Total cell yields were calculated using a hemocytometer and 0.4% trypan blue to assess the viability of cells kept in RPMI 1640 (Invitrogen, Carlsbad, CA, USA) medium with 10% fetal bovine serum (Hyclone, Logan, UT, USA).
ELISPOT assay
The ELISPOT technique was performed as described previously. 17 Briefly, spleen, lung, PP, MLN and NALT cells were incubated with 10 mg/ml of ESAT-6 peptide (1-20 aa) in a 96-well plate coated with rat anti-mouse IFN-c and IL-4 mAbs (BD Biosciences, San Diego, CA, USA) or ConA (5 mg/ml; Sigma-Aldrich, St Louis, MO, USA) as a positive control for 36 h. Cytokine production was detected using biotin-labeled rat anti-mouse IFN-c and IL-4 mAb (BD Biosciences) and probed with alkaline phosphatase-conjugated streptavidin (BD Biosciences). The enzyme reaction was developed with 5-bromo-4-chloro-3-indolyl-phosphate/nitro blue tetrazolium (Sigma-Aldrich), 
CTL assay in vivo
The 5-and 6-carboxyfluorescein diacetate succinimidyl ester (CFSE) assay used in this study demonstrated ESAT-6-specific cytotoxicity T lymphocyte effector function in vivo by flow cytometry. In vivo cytotoxic activity initiated by SL5928(fliC/esat) was established using a murine model. The donor cells were prepared from the spleen of naïve mice, washed three times with PBS and divided into two populations. One population (as target cells), CFSE high cells, was pulsed with 10 mM ESAT-6-specific peptide (1-20 aa), incubated at 37 uC for about 45 min and then labeled with a high concentration of the fluorescent dyes CFSE (5.0 mM). The second control population, dyestuff CFSE low cells, was left without peptide and labeled with a low concentration of CFSE (0.25 mM). The CFSE low and CFSE high cells were mixed together (a total of 2310 7 cells) at a 2 : 1 ratio from each population and injected into each immunized mouse (7 days after the second immunization) via the tail vein. Splenocytes were isolated from the spleens of sacrificed mice 15 h later and analyzed by flow cytometry. The following formulas were used:
Ratio5percentage CFSE low /percentage CFSE high Percentage specific lysis512(ratio unprimed/ratio primed)3100%.
Statistical methods Data obtained were tested by SPSS 13.0. Differences between means were assessed for statistical significance using Student's t-test. A value of P,0.05 was considered to be significant.
RESULTS
Construction and identification of the chimeric flagellin specifying ESAT-6 antigen Specific primers were designed based on the Stm flagellin fliC i gene sequence to amplify the fliC i gene. Similarly, the ESAT-6 coding sequence was also amplified by PCR using specific primers. Overlap PCR was further used to synthesize the chimeric flagellin gene, and the ESAT-6 coding fragment was inserted into the unique hypervariable region of fliC. The recombinant plasmid carrying the chimeric flagellin gene was sequenced and named pET-fliC/esat. Salmonella SL5928(fliC/esat) were transduced with the chimeric flagellin, and the inserted ESAT-6 antigen was identified by western blot analysis. Western blot analysis using the anti-ESAT-6 mAb HYB 076-08 confirmed that the 52-kDa band corresponded to the chimeric fliC/esat protein ( Figure 2 ).
Swarming and electron microscopy of transduced cells
Swarming was observed within 6-8 h. Flagellated SL5928(fliC/esat) produced smooth swarming when compared with the SL5928 control ( Figure 3 ). Electron microscopy revealed that flagellated SL5928(fliC/ esat) expressed flagella similar to the wide-type control strain SL1438 (Figure 4) .
Cytokine production following i.n. immunization with flagellated Salmonella SL5928(fliC/esat) To measure the cellular immune responses elicited by i.n. administration of SL5928(fliC/esat), cytokine production of IFN-c and IL-4 levels were quantified using an ELISPOT assay. The mean numbers of IFN-c-producing cells (spots/10 6 cells) in the lung (216.67655.08), PPs (52.5610.02) and NALT (65.065.0) were significantly increased (P,0.01) in SL5928(fliC/esat)-immunized mice compared to the SL5928-immunized control group ( Figure 5) . The difference between the SL5928(fliC/esat)-immunized group and PBS control was also significant (P,0.01). However, the numbers of IL-4-producing cells from lungs, PPs and NALTs were significantly lower compared to those of IFN-c-producing cells, independent of treatment group. The numbers of ESAT-6-specific IFN-c-producing and IL-4-producing cells from spleen and MLNs were higher in the SL5928(fliC/ esat)-immunized mice than in the SL5928-immunized group and the control group ( Figure 5 ). These results suggest that mice receiving SL5928(fliC/esat) developed cellular immune responses against the ESAT-6 protein.
CTL effects in vivo
In this study, we provide evidence that ESAT-6-specific memory CD8 1 T cells exert substantial Ag-specific cytotoxicity in vivo. We used CFSE to evaluate ESAT-specific cytotoxic T lymphocyte effector function in vivo by flow cytometry. As target cells, spleen cells from uninfected mice were pulsed with ESAT-6 peptide or left untreated. Each group was then labeled with different levels of CFSE and coadministered to animals that had been previously immunized with 1 T cells in the spleens of recipient mice was compared with that of the donor cell population that had not been pulsed with ESAT-6 peptide. At 15 h post-transfer into mice infected by SL5928(fliC/esat) or SL5928(fliC), .75% of ESAT-6 peptidepulsed donor cells were cleared from the spleen ( Figure 6 ). In spleens of mice infected by SL5928(fliC), the frequencies of ESAT-6 peptidepulsed and untreated donor cells were equal to the initial ratio ( Figure  6 ). The marked efficiency in eliminating ESAT-6 peptide-pulsed target cells demonstrated the CTL activity of memory CD8 1 T cells in SL5928(fliC/esat) immunized mice.
DISCUSSION
Recently, over 170 TB vaccine candidates have been tested in animal TB models 18 using a variety of strategies, including DNA vaccines, subunits, recombinant BCGs and live attenuated vaccines. However, inconsistent results have been reported from these experimental models. Because protective immunity against TB requires the elicitation of cell-mediated immunity, it is necessary for candidate vaccines to elicit an effective cellular immune response or a CTL response. ESAT-6, which was originally isolated from a low-molecular-mass fraction of an MTB culture filtrate, is encoded by the RD1 region of MTB. ESAT-6 is a potent T-cell antigen and a diagnostic target for MTB and Mycobacterium bovis infection.
Bacterial flagellins have been studied for decades due to the importance of these proteins in bacterial motility and their adjuvant characteristics in vaccine studies. Flagellin is a highly conserved bacterial protein that elicits TLR-5-dependent inflammatory responses in both animal and plants. 19 Previous studies have investigated the ability of flagellin to elicit antigen-specific T-cell responses when delivered as live attenuated vaccines. 20, 21 In addition, Salmonella flagellin has previously been used as an adjuvant and carrier for a synthetic peptide and to potentiate antibody production against a cholera toxin epitope. 22, 23 Chimeric flagellin products are functional unless the 59 and 39 coding frames, which encode the regions important for secretion and polymerization of flagellin, are changed. In the Salmonella fliC i gene, the 59 and 39 conserved regions are represented by 519 bp (encoding the Nterminal 173 amino-acid residues) and 270 bp (C-terminal 90 residues) sequences, respectively, separated by a highly variable region. 24 We therefore generated a flagellated Salmonella in which the coding region for amino-acid resides 205-232 of the flagellin was replaced with the entire coding sequence for ESAT-6 of MTB. This 'hypervariable' sequence region varies greatly in size and composition for different strains and species. However, our study demonstrated that flagellin function did not change after the foreign antigen was inserted. Furthermore, ESAT-6 expression was verified by western blotting using a specific anti-ESAT-6 monoclonal antibody HYB 076-08 (data not shown). Characterization of the cytokine response following SL5928(fliC/ esat) or SL5928 immunization was carried out by ELISPOT and identified lung, PP, NALT, spleen and MLN cells that produced IFN-c and IL-4 in response to ESAT-6 peptide stimulation. These experiments demonstrated that in mucosal-associated lymphoid tissues, such as lungs, PPs and NALTs, an anti-ESAT-6 response was Th1-associated based on the significant elevation of the Th1-associated cytokine IFNc. In contrast, cells harvested from spleen and MLN produced a mixed Th1/Th2-type response based on the elevated levels of both IFN-c and IL-4. Our study therefore demonstrated that a Th1-associated immune response following i.n. vaccination with flagellated Salmonella SL5928(fliC/esat) was observed in the lungs, PPs and NALTs. Previous studies have also demonstrated that flagellated Salmonella is an effective delivery system. One study reported that the product of the gene Rv2108 of MTB expressed in flagellin also produced the strongest Th1-like immune response. 25 Manocha et al. further demonstrated that intranasal immunization of mice with Fla-91-a recombinant flagellin containing the influenza B-cell epitope HA91-108-led to partial protection of mice from viral challenge. 26 High-level T-cell responses and increased IL-2 or IFN-c cytokine production from PPs have also been detected following i.n. immunization. 27 However, the mechanisms producing such specific immune responses in PPs remain unclear.
The induction of a Th1-like immune response to flagellin was demonstrated by i.n. immunization. Various routes of immunization have been investigated, including intramuscular (i.m.), i.n. and subcutaneous vaccination, as well as numerous methods of antigen delivery, such as co-encapsulation in poly-lactic acid microspheres, 28, 29 expression by Salmonella 30-32 and DNA vaccination. 33, 34 However, our experiments suggest that i.n. immunization may be the most useful method for preventing infectious respiratory diseases.
In addition, CTL responses based on CFSE in vivo were tested using flow cytometry to demonstrate whether chimeric flagellated Salmonella can induce ESAT-6-specific CTL effects. The results showed that memory T cells in the spleen of recipient mice immunized with SL5928(fliC/esat) play a substantial part in clearing the ESAT-6 peptide-pulsed target cells. In other words, ESAT-6-specific memory CD8 1 T cells exert substantial Ag-specific cytotoxicity in vivo. Similarly, Braga et al. also demonstrated that recombinant S. dublin flagella expressing the target CS (280-288) (the 9-mer (SYVPSAEQI) synthetic H2(d)-restricted CD8
1 T cell-specific epitope) peptide fused at the central hypervariable domain were able to prime cytotoxic CD8 1 T cells. 13 Therefore, flagellated Salmonella may also offer protection by inducing efficient CTL responses.
Our study using flagellated Salmonella administered i.n has demonstrated that flagella represent a microbial surface display system that can function as a delivery system for foreign antigen in vivo. Live, attenuated and flagellated Salmonella may therefore be a cost-effective prophylactic measure against mucosal disease.
